摘要
目的:观察地尔硫卓、尼卡地平预防气管插管期心血管反应的疗效。方法:将60例ASAⅠ~Ⅱ级的成年患者随机分为生理盐水组(C组)、尼卡地平15μg/kg组(N组)、地尔硫卓0.2 mg/kg组(D组)。在气管插管前2 min静脉推注。记录诱导前、给药时、给药后、气管插管时及插管后1、2、3 min的血压(BP)、心率(HR)、心搏指数(SVI),心指数(CI),计算心率收缩压乘积(RPP=心率×收缩压)。结果:插管后C组平均动脉压(MAP)、HR的峰值较基础值上升21.7%、31.1%(P<0.01);D组插管后MAP、HR均无明显增高,变化小于C组(P<0.05);N组插管后MAP无显著变化,但HR的峰值较基础值升高42.5%。静注地尔硫卓、尼卡地平后CI、SVI较给药前增加。结论:尼卡地平可减轻气管插管的升压反应,但不能防止心动过速的发生;地尔硫卓可有效抑制气管插管时的心血管不良反应。
Objective: To observe the efficacy of Nicardipine and Diltiazem in attenuation the cardiovascular responses to laryngoscopy and tracheal intubation(LTI).Methods: 60 patients of ASA Ⅰ-Ⅱ were assigned to one of the following 3 groups at random,normal saline(group C),0.2 mg/kg Diltiazem(group D) or 15 μg/kg Nicardipine(group N).The medication for study was administered intravenously 2 minutes before the initiation of LTI.Blood pressure(BP),heart rate(HR),stroke volume index(SVI) and cardiac index(CI) were recorded at designed time points,before induction,immediate and after the bolus injection,immediate and 1,2,3 min after LTI.Rate-pressure product(RPP) were calculated.Results: After intubation,the peak MAP and HR values in group C increased by 21.7% and 31.1% over the baseline values(P0.01);changes of MAP and HR after tracheal intubation in group D were less than those in group C(P0.05);In group N,the increase in MAP provoked by LTI were less than group C and HR increased by 42.5% over the baseline;CI,SVI increased slightly after the bolus of Diltiazem and Nicardipine.Conclusion: Nicardipine is effective in attenuating pressure response to tracheal intubation but can not prevent tachycardia;Diltiazem produced greater attenuation on the circulatory responses to tracheal intubation.
出处
《中国医药导报》
CAS
2011年第29期84-86,共3页
China Medical Herald
关键词
地尔硫卓
尼卡地平
气管插管
心血管反应
Diltiazem
Nicardipine
Laryngoscopy and tracheal intubation
Cardiovascular responses